Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2017 (2017), Article ID 2795432, 8 pages
https://doi.org/10.1155/2017/2795432
Research Article

High Serum Alkaline Phosphatase, Hypercalcaemia, Race, and Mortality in South African Maintenance Haemodialysis Patients

Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Correspondence should be addressed to Bala Waziri

Received 1 October 2016; Revised 12 November 2016; Accepted 14 December 2016; Published 12 January 2017

Academic Editor: Jaime Uribarri

Copyright © 2017 Bala Waziri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. L. Lau and K. Kalantar-Zadeh, “Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures,” Nephrology Dialysis Transplantation, vol. 29, no. 8, pp. 1450–1452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, “KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD),” Kidney International, vol. 76, supplement 113, pp. S1–S130, 2009. View at Google Scholar
  3. K. A. Lomashvili, P. Garg, S. Narisawa, J. L. Millan, and W. C. O'Neill, “Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification,” Kidney International, vol. 73, no. 9, pp. 1024–1030, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. W. C. O'Neill, “Pyrophosphate, alkaline phosphatase, and vascular calcification,” Circulation Research, vol. 99, no. 2, article e2, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. K. Sigrist, M. W. Taal, P. Bungay, and C. W. McIntyre, “Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 6, pp. 1241–1248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Shantouf, C. P. Kovesdy, Y. Kim et al., “Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 6, pp. 1106–1114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. V. Badve, L. Zhang, J. S. Coombes et al., “Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial,” Canadian Journal of Kidney Health and Disease, vol. 2, no. 33, 2015. View at Publisher · View at Google Scholar
  8. K. C. Norris, K. Kalantar-Zadeh, and J. D. Kopple, “The role of race in survival among patients undergoing dialysis,” Nephrology News & Issues, vol. 25, no. 13, pp. 13–16, 2011. View at Google Scholar · View at Scopus
  9. G. Yan, K. C. Norris, A. J. Yu et al., “The relationship of age, race, and ethnicity with survival in dialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 8, no. 6, pp. 953–961, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. J. Scialla, R. S. Parekh, J. A. Eustace et al., “Race, mineral homeostasis and mortality in patients with end-stage renal disease on dialysis,” American Journal of Nephrology, vol. 42, no. 1, pp. 25–34, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Robinson-Cohen, A. N. Hoofnagle, J. H. Ix et al., “Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events,” The Journal of the American Medical Association, vol. 310, no. 2, pp. 179–188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Floege, J. Kim, E. Ireland et al., “Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population,” Nephrology Dialysis Transplantation, vol. 26, no. 6, pp. 1948–1955, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. B. O. Lightfoot, R. J. Caruana, L. L. Mulloy, and M. E. Fincher, “Simple formula for calculating normalized protein catabolic rate (NPCR) in haemodialysis (HD) patients (abstract),” Journal of the American Society of Nephrology, vol. 4, p. 363, 1993. View at Google Scholar
  14. M. J. Blayney, R. L. Pisoni, J. L. Bragg-Gresham et al., “High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death,” Kidney International, vol. 74, no. 5, pp. 655–663, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Beige, R. Wendt, M. Girndt, K.-H. Queck, R. Fiedler, and P. Jehle, “Association of serum alkaline phosphatase with mortality in non-selected european patients with ckd5d: an observational, three-centre survival analysis,” BMJ Open, vol. 4, no. 2, Article ID e004275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. D. L. Regidor, C. P. Kovesdy, R. Mehrotra et al., “Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients,” Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2193–2203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Kalantar-Zadeh, N. Kuwae, D. L. Regidor et al., “Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients,” Kidney International, vol. 70, no. 4, pp. 771–780, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. G. A. Block, P. S. Klassen, J. M. Lazarus, N. Ofsthun, E. G. Lowrie, and G. M. Chertow, “Mineral metabolism, mortality, and morbidity in maintenance hemodialysis,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2208–2218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Cunningham and J. Silver, “CKD-MBD: comfort in the trough of the U,” Nephrology Dialysis Transplantation, vol. 26, no. 6, pp. 1764–1766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Beddhu, X. Ma, B. Baird, A. K. Cheung, and T. Greene, “Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 11, pp. 1805–1810, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Tonelli, G. Curhan, M. Pfeffer et al., “Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality,” Circulation, vol. 120, no. 18, pp. 1784–1792, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Schoppet and C. M. Shanahan, “Role for alkaline phosphatase as an inducer of vascular calcification in renal failure?” Kidney International, vol. 73, no. 9, pp. 989–991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. B. M. Y. Cheung, K. L. Ong, R. V. Cheung et al., “Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese,” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 4, pp. 523–527, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. G. Hanley, K. Williams, A. Festa, L. E. Wagenknecht, R. B. D'Agostino Jr., and S. M. Haffner, “Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study,” Diabetes, vol. 54, no. 11, pp. 3140–3147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. R. Chaudhuri, K. R. Mridula, A. Anamika et al., “Deficiency of 25-hydroxyvitamin d and dyslipidemia in Indian subjects,” Journal of Lipids, vol. 2013, Article ID 623420, 7 pages, 2013. View at Publisher · View at Google Scholar
  26. P. Lips, T. Duong, A. Oleksik et al., “A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 3, pp. 1212–1221, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Tentori, M. J. Blayney, J. M. Albert et al., “Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS),” American Journal of Kidney Diseases, vol. 52, no. 3, pp. 519–530, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. G. M. London, S. J. Marchais, A. P. Guérin, P. Boutouyrie, F. Métivier, and M.-C. de Vernejoul, “Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD,” Journal of the American Society of Nephrology, vol. 19, no. 9, pp. 1827–1835, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Noordzij, E. M. Cranenburg, L. F. Engelsman et al., “Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients,” Nephrology Dialysis Transplantation, vol. 26, no. 5, pp. 1662–1669, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Tanaka, S. Yamazaki, Y. Hayashino et al., “Hypercalcaemia is associated with poor mental health in haemodialysis patients: results from Japan DOPPS,” Nephrology Dialysis Transplantation, vol. 22, no. 6, pp. 1658–1664, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. E. G. Lowrie and N. L. Lew, “Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities,” American Journal of Kidney Diseases, vol. 15, no. 5, pp. 458–482, 1990. View at Publisher · View at Google Scholar · View at Scopus
  32. E. W. Young, J. M. Albert, S. Satayathum et al., “Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study,” Kidney International, vol. 67, no. 3, pp. 1179–1187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. L. M. Kucirka, M. E. Grams, J. Lessler et al., “Association of race and age with survival among patients undergoing dialysis,” The Journal of the American Medical Association, vol. 306, no. 6, pp. 620–626, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Streja, C. P. Kovesdy, M. Z. Molnar et al., “Role of nutritional status and inflammation in higher survival of African American and hispanic hemodialysis patients,” American Journal of Kidney Diseases, vol. 57, no. 6, pp. 883–893, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. D. C. Crews, S. M. Sozio, Y. Liu, J. Coresh, and N. R. Powe, “Inflammation and the paradox of racial differences in dialysis survival,” Journal of the American Society of Nephrology, vol. 22, no. 12, pp. 2279–2286, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. U. Feroze, N. Noori, C. P. Kovesdy et al., “Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 5, pp. 1100–1111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. A. N. Friedman and S. Z. Fadem, “Reassessment of albumin as a nutritional marker in kidney disease,” Journal of the American Society of Nephrology, vol. 21, no. 2, pp. 223–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. W. E. Mitch, “Malnutrition: a frequent misdiagnosis for hemodialysis patients,” The Journal of Clinical Investigation, vol. 110, no. 4, pp. 437–439, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. O. M. Gutiérrez, W. R. Farwell, D. Kermah, and E. N. Taylor, “Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey,” Osteoporosis International, vol. 22, no. 6, pp. 1745–1753, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Wolf, J. Betancourt, Y. Chang et al., “Impact of activated vitamin D and race on survival among hemodialysis patients,” Journal of the American Society of Nephrology, vol. 19, no. 7, pp. 1379–1388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. L. Melamed, J. A. Eustace, L. Plantinga et al., “Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study,” Kidney International, vol. 70, no. 2, pp. 351–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Wald, M. J. Sarnak, H. Tighiouart et al., “Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the hemodialysis (HEMO) Study,” American Journal of Kidney Diseases, vol. 52, no. 3, pp. 531–540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Fukagawa, R. Kido, H. Komaba et al., “Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding,” American Journal of Kidney Diseases, vol. 63, no. 6, pp. 979–987, 2014. View at Publisher · View at Google Scholar · View at Scopus